CX3CR1 is dysregulated in blood and brain from schizophrenia patients

- Bergon, Aurélie, Belzeaux, Raoul, Kelly, Brian, Cairns, Murray J., Kumarasinghe, Nishantha, Schall, Ulrich, Blin, Olivier, Boucraut, José, Tooney, Paul A., Fakra, Eric, Ibrahim, El Chérif, Comte, Magali, Pelletier, Florence, Hervé, Mylène, Gardiner, Erin J., Beveridge, Natalie J., Liu, Bing, Carr, Vaughan, Scott, Rodney J.

Different forms of glycine- and GABAᴀ-receptor mediated inhibitory synaptic transmission in mouse superficial and deep dorsal horn neurons

- Anderson, Wayne B., Graham, Brett A., Beveridge, Natalie J., Tooney, Paul A., Brichta, Alan M., Callister, Robert J.

Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation

- Beveridge, Natalie J., Tooney, Paul A., Carroll, Adam P., Tran, Nham, Cairns, Murray J.

Dysregulation of miRNA 181b in the temporal cortex in schizophrenia

- Beveridge, Natalie J., Tooney, Paul A., Carroll, Adam P., Gardiner, Erin, Bowden, Nikola A., Scott, Rodney J., Tran, Nham, Dedova, Irina, Cairns, Murray J.

Expression of NPAS3 in the human cortex and evidence of its posttranscriptional regulation by miR-17 during development, with implications for schizophrenia

- Wong, Jenny, Duncan, Carlotta E., Beveridge, Natalie J., Webster, Maree J., Cairns, Murray J., Weickert, Cynthia Shannon

Gene expression analysis reveals schizophrenia-associated dysregulation of immune pathways in peripheral blood mononuclear cells

- Gardiner, Erin J., Cairns, Murray J., Liu, Bing, Beveridge, Natalie J., Carr, Vaughan, Kelly, Brian, Scott, Rodney J., Tooney, Paul A.

Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication

- Kumarasinghe, Nishantha, Beveridge, Natalie J., Gardiner, Erin, Scott, Rodney J., Yasawardene, Surangi, Perera, Antoinette, Mendis, Jayan, Suriyakumara, Kanishka, Schall, Ulrich, Tooney, Paul A.

Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine

- Santarelli, Danielle M., Liu, Bing, Duncan, Carlotta E., Beveridge, Natalie J., Tooney, Paul A., Schofield, Peter R., Cairns, Murray J.

MicroRNA dysregulation in schizophrenia

- Beveridge, Natalie J., Cairns, Murray J.

Non-coding RNAs and psychiatric disorders

- Peedicayil , Jacob, Beveridge, Natalie J.

Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repair

- Budden, Timothy, Davey, Ryan J., Vilain, Ricardo E., Ashton, Katie A., Braye, Stephen G., Beveridge, Natalie J., Bowden, Nikola A.

Transcriptome sequencing revealed significant alteration of cortical promoter usage and splicing in schizophrenia

- Wu, Jing Qin, Wang, Xi, Beveridge, Natalie J., Tooney, Paul A., Scott, Rodney J., Carr, Vaughan J., Cairns, Murray J.

Understanding xeroderma pigmentosum complementation groups using gene expression profiling after UV-light exposure

- Bowden, Nikola A., Beveridge, Natalie J., Ashton, Katie A., Baines, Katherine J., Scott, Rodney J.

Upregulation of dicer and MicroRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia

- Santarelli, Danielle M., Beveridge, Natalie J., Tooney, Paul A., Cairns, Murray J.